Modern Diagnostic IPO GMP, Price, Analysis, And Details

Modern Diagnostic & Research Centre IPO under the SME IPO category is a bookbuild issue of Rs. 36.89 Cr by Modern Diagnostic & Research Centre Limited and is a chain of diagnostic facilities in India that provides a wide range of radiology and pathology services.

For institutional clients and patients, the company offers dependable diagnostic tests, online reports, home specimen collection, and customized test packages tailored to their specific needs. Offering diagnostic services like ultrasound, CT, MRI, X-ray, ECG, PFT, and specialist labs for heart and neuro care, the company runs 21 sites (18 laboratories, 3 diagnostic centers) throughout 8 states.

Services:

Pathology

Radiology

Collecting Samples at Home.

Modern Diagnostic & Research Centre IPO Details

The Modern Diagnostic & Research Centre IPO date of opening is 31 Dec 2025, its initial public offering will end on 02 Jan 2026, IPO allotment on Jan 05 and refund initiation on Jan 06, 2026.

The Rs. 36.89 crore new SME IPO comprises a wholly fresh issue of 0.41 crore shares.

The Modern Diagnostic & Research Centre IPO listing date (expected) might be on Wednesday, Jan 07, 2026 and listing at the BSE and SME. 

The Modern Diagnostic & Research Centre IPO price band is Rs. 85 to Rs. 90.

IPO Timetable (Tentative)

Events	Date
IPO Opening Date	Dec 31, 2025
IPO Closing Date	Jan 02, 2026
IPO Allotment Date	Jan 05, 2026
Refund Initiation	Jan 06, 2026
IPO Listing Date	Jan 07, 2026

 

Click to open demat account and apply for the IPO.

 

 

Company Financials

(Amount in Cr)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	64.57	49.49	36.54
Total Income	78.80	68.67	56.61
PAT	8.97	5.79	-5.73
EBITDA	17.96	11.05	-0.99
Net Worth	20.73	11.76	5.96
Reserves & Surplus	9.73	10.76	4.96
Total Borrowing	22.09	20.46	15.31

 

Cash Flows

(Amount in lac)

Net Cash Flow	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	1,373.21	792.87	-11.89
Net Cash Flow Investing Activities	-1,314.28	-1,103.21	210.83
Net Cash Flow Financing Activities	-21.74	336.19	-647.34

 

Revenue Bifurcation

(Rs. in Lac)

(Source: RHP)

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Funding capital expenditure for the purchase of medical equipment for the diagnostic centre and laboratories. ~ Rs. 20.69 Cr.

• Funding working capital requirements. ~ Rs. 8 Cr.

• Repayment of certain outstanding borrowings availed by the Company. ~ Rs. 1 Cr.

• General Corporate Purposes.
  
  

Listed Peers of Modern Diagnostic & Research Centre Ltd.

Name of the Company	Face Value (Rs.)	EPS (Rs.)	P/E Ratio (x)
Vijaya Diagnostic Centre Limited	1	13.92	72.36

 

Valuation

KPI	Value
ROE	55.21%
ROCE	36.18%
Debt / Equity	1.07
RoNW	43.27%
PAT Margin	11.51%
EBITDA Margin	23.04%
PB Value	4.78

 

 

Evaluation of P/E Ratio

Considering the period ended on FY 2025 with an EPS of Rs. 8.15 from the last year, the resulting P/E ratio is 11.04x.

Explore the Bai Kakaji IPO.

IPO's Strengths

• Skilled management team and promoter.

• All-in-one solutions from a comprehensive diagnostics supplier at affordable costs.

• Put quality and customer service first.

• platform for centralized information technology.

 

IPO’s Weaknesses 

• Our capacity to process diagnostic tests may be impacted by any disruptions at our labs and diagnostic facilities.

• If we can't sustain and expand our brand name and image, business and prospects may suffer.

• Significant reliance on essential diagnostic tools and fundamental technology infrastructure may exist, and their failure could cause major service interruptions.
  
  

Modern Diagnostic & Research Centre IPO GMP (Grey Market Premium)

Modern Diagnostic & Research Centre IPO GMP today has not started yet as of 25 Dec 2025 while writing this information.

Modern Diagnostic & Research Centre IPO Summary

IPO Opening & Closing Date	31 Dec, 2025 to 02 Jan, 2026
Face Value	Rs. 10 per Share
Issue Price	Rs. 85 to Rs. 90 per Share.
Lot Size	1600 Shares
Issue Size	40,99,200 Shares (Rs. 36.89 Cr)
Offer for Sale	-
Fresh Issue	40,99,200 Shares (Rs. 36.89 Cr)
Listing at	BSE, SME
Issue Type	Bookbuild issue IPO
Registrar	MUFG Intime India Pvt. Ltd.

 

IPO Lot Details 

Retail investors can invest in a minimum of 2 Lots (3200 Shares) for Rs. 2,88,000, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (4800 Shares) for Rs. 4,32,000.

Minimum Lot Investment (Retail)	2 Lots
Maximum Lot Investment (Retail)	2 Lots
HNI (Min)	3 Lots

 

Modern Diagnostic & Research Centre IPO Allotment Status

To check the Modern Diagnostic & Research Centre IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of Modern Diagnostic & Research Centre Ltd.

• Mr. Devendra Singh Yadav

• Mrs. Deepali Yadav

• Mrs. Asha Yadav

• Mr. Jitendra Singh.

Pre-Issue Promoter Shareholding	99.99%
Post-Issue Promoter Shareholding	72.85%

 

IPO Lead Managers

• Beeline Capital Advisors Pvt. Ltd. 
  
  

Dividend Policy

The company has not paid a dividend during the last three financial years.

 

Conclusion

Exposure to India's rapidly developing healthcare diagnostics market with robust profitability measures and growing service reach is provided by the Modern Diagnostic & Research Centre IPO. It has increasing margins, asset growth and fair value in comparison to listed peers. Before making an investment, investors should take operational risks and reliance on diagnostic infrastructure into account.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.